Experienced StHealth Capital Advisory Team reduces investments risks and provides high-growth strategy
Evaluates exit opportunities: IPOs, secondary and strategic sales as well as royalty monetization
- BDC provides access to this expert management team and significant upside potential through early investment
Validation or modification of portfolio business plan & forecasts
- Clinical, Medical, or Scientific guidance through Regulatory requirements
- Identification and facilitation of commercial and business development partnerships, both domestic and international
- Identify cost-cutting, revenue enhancement opportunities
Portfolio company management absorbed into StHealth Capital’s advisory board
- Represented by affiliations or experience at many premier institutions
Derek Taller, Ph.D.
Chief Executive Officer
Dr. Derek Taller previously served as Managing Director of LG Investments, a New York-based Multi-Family Office. Dr. Taller has a broad range of expertise in healthcare, and has originated, structured and executed both public and private investment and financing deals. His expertise is further demonstrated by his involvement in leading companies that he supported through managing multiple healthcare equity portfolios and forming fund vehicles to help execute on lucrative corporate strategies and partnerships.
Dr. Taller focuses on innovative product technologies, strategy, growth, management buyouts and global strategic alliances. His strategy emphasizes transformational healthcare and under-the-radar market opportunities through data analytics, superior innovation, and globalization. He also focuses on a distribution channel for products through large domestic hospital networks and in overseas countries. Dr. Taller is also involved in policy making to advance the adoption of breakthrough medical products.
Prior to StHealth Capital, Dr. Taller was a Senior Manager at Benchmark and was involved in the formation of a healthcare fund vehicle. His buy-side experience also spans from being a Portfolio Manager at Xmark Partners to Stratix Asset Management where he managed a healthcare fund for public investments.
Previously, Dr. Taller conducted research at New York Medical/Rockefeller, King’s College London, Princeton, UC Berkeley and UCSF. He holds a Ph.D. from the Cancer Institute of New Jersey-RWJ Medical School and an A.B. in Molecular Biology from U.C. Berkeley.
David Lessen, Ph.D.
Chief Financial Officer / Chief Operating Officer
Dr. David Lessen has over 25 years of financial experience. He was previously the Chief Financial Officer and member of the Board of Directors of Cerebral Assessment Systems, which produced Cognivue, the first FDA-cleared medical device for the detection and measurement of dementia and cognitive impairment. Concurrently, he was a Managing Director at Atlas Financial Partners, which provides proprietary structured financial solutions for corporate clients.
Previously, Dr. Lessen worked for approximately 20 years in investment banking and capital markets. He worked for nine of those years at UBS Investment Bank, where he was a Managing Director in the Global Healthcare Group and led the origination of more than $12 billion notional amount of convertible bond financings and equity derivative transactions in the Healthcare sector. He has also been a Managing Director and Head of Convertible Bond Origination at Broadpoint Gleacher and previously held various capital markets positions at Zurich Capital Markets, JP Morgan, Toronto Dominion and Goldman Sachs.
Dr. Lessen received both a BSc in Mechanical Engineering and a Master’s degree in Aerospace Engineering from Cornell University. He received a Ph.D. in Theoretical and Applied Mechanics from Rensselaer Polytechnic Institute and an MBA from Cornell University’s Johnson Graduate School of Management.
Senator Ron A. Silver
Board Member and Government Contracting Leader
Senator Ronald A. Silver was first elected to the Florida House of Representatives in 1978, and continued his tenure in that body until 1992. While in the Florida House, Senator Silver served in major positions, including Majority Whip (1984-1986) and Majority Leader (1986-1988). He also chaired various committees, including the Select Committee on Juvenile Justice, Criminal Justice, Ethics and Elections, as well as the Subcommittee of Appropriations on General Government.
Senator Silver was then elected to the Florida Senate in 1992 and subsequently re-elected, serving as the Majority (Democratic) leader for the 1994 session. During his last term in the Senate, he was designated by both the House and Senate as the Dean of the Legislature recognizing his standing as the longest serving member.
His career as a lawmaker has yielded a vast and extensive knowledge of public policy issues and the legislative process, allowing him to be an advocate and servant for his diverse community. Throughout his tenure in the Senate, Mr. Silver has been known to tackle tough issues, transcend partisanship and build strong coalitions. As Senator, he served on a variety of committees, and was chairman of both the Appropriations Subcommittee on Health and Human Services and Criminal Justice. His career in the Senate has earned praise from his colleagues, in both the legislature and other branches of government throughout the nation.
In 1993, Mr. Silver was elected Chairman of the Southern Legislative Conference (17 Southern States) of the Council of State Governments. Most recently, a new prescription drug plan for Medicare-eligible senior citizens in the State of Florida has been named the “Silver Saver” in his honor.
Since his retirement from the Senate in 2002, Mr. Silver also functions as President of his own consulting firm (Ron Silver & Associates) and maintains his law practice in Miami Beach, Florida. In addition, Mr. Silver served as the first chairman of the Florida Biofuels Association and is currently the immediate past chairman and a Member of the Board Directors of that organisation.